Exelixis Inc Increase (Decrease) in Other Operating Assets
Exelixis Inc (EXEL) reported Increase (Decrease) in Other Operating Assets of $2.15 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2015-03-02
- Exelixis Inc increase (decrease) in other operating assets for the quarter ending 2014-03-31 was $5.00K.
- Exelixis Inc increase (decrease) in other operating assets for the quarter ending 2013-12-31 was $0.00.
- Exelixis Inc increase (decrease) in other operating assets for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc increase (decrease) in other operating assets for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc increase (decrease) in other operating assets for fiscal 2014 was $2.15M.
- Exelixis Inc increase (decrease) in other operating assets for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Exelixis Inc increase (decrease) in other operating assets for fiscal 2012 was $1.97M.
- Exelixis Inc increase (decrease) in other operating assets for fiscal 2011 was -$405.00K, a 122.41% decline from fiscal 2010.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2014-12-31 | $2.15M 10-K · filed 2015-03-02 | |||
| 2014-03-31 | $5.00K 10-Q · filed 2014-05-01 | $5.00K derived: sum of 2 quarters · filed 2015-03-02 | $5.00K derived: sum of 3 quarters · filed 2015-03-02 | $5.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $0.00 derived: sum of 3 quarters · filed 2015-03-02 | $0.00 10-K · filed 2015-03-02 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 | -$17.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | -$17.00K derived: sum of 3 quarters · filed 2015-03-02 | $1.74M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-01 | -$17.00K derived: sum of 2 quarters · filed 2015-03-02 | $1.74M derived: sum of 3 quarters · filed 2015-03-02 | $1.85M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.74M derived: sum of 2 quarters · filed 2015-03-02 | $1.85M derived: sum of 3 quarters · filed 2015-03-02 | $1.97M 10-K · filed 2015-03-02 |
| 2012-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $1.87M derived: sum of 2 quarters · filed 2013-10-30 | $1.98M 10-Q · filed 2013-10-30 | $2.28M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $224.00K 10-Q · filed 2013-08-06 | $520.00K derived: sum of 3 quarters · filed 2014-02-20 | $51.00K derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | $116.00K 10-Q · filed 2013-05-07 | $412.00K derived: sum of 2 quarters · filed 2014-02-20 | -$57.00K derived: sum of 3 quarters · filed 2014-02-20 | -$175.00K derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$173.00K derived: sum of 2 quarters · filed 2014-02-20 | -$291.00K derived: sum of 3 quarters · filed 2014-02-20 | -$405.00K 10-K · filed 2014-02-20 |
| 2011-09-30 | -$469.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$587.00K derived: sum of 2 quarters · filed 2012-11-07 | -$701.00K 10-Q · filed 2012-11-07 | -$614.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | -$118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$232.00K 10-Q · filed 2012-08-02 | -$145.00K derived: sum of 3 quarters · filed 2013-02-21 | -$126.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | -$114.00K 10-Q · filed 2012-05-03 | -$27.00K derived: sum of 2 quarters · filed 2013-02-21 | -$8.00K derived: sum of 3 quarters · filed 2013-02-21 | |
| 2010-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $106.00K derived: sum of 2 quarters · filed 2013-02-21 | $1.81M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $1.72M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $1.70M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$6.42M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |